VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

0
Player Avatar AjmalmirzA (< 20) Submitted: 11/10/2010 8:14:38 PM : Outperform Start Price: $6.70 VVUS Score: +257.89

Its time, there is compete

Featured Broker Partners


Advertisement